HK Stock MarketDetailed Quotes

CHINLINK INTL (00997)

Watchlist
  • 0.022
  • +0.001+4.76%
Market Closed Apr 17 15:20 CST
25.72MMarket Cap-0.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CHINLINK INTL (00997) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Sep 30, 2025
(FY)Mar 31, 2025
(Q6)Sep 30, 2024
(FY)Mar 31, 2024
(Q6)Sep 30, 2023
(FY)Mar 31, 2023
(Q6)Sep 30, 2022
(FY)Mar 31, 2022
(Q6)Sep 30, 2021
(FY)Mar 31, 2021
Turnover
-19.57%35.73M
-18.48%79.3M
-5.90%44.43M
-18.10%97.28M
-24.68%47.21M
-20.25%118.77M
-34.70%62.68M
-33.42%148.94M
-17.24%95.99M
-47.43%223.68M
Operating income
-19.57%35.73M
-18.48%79.3M
-5.90%44.43M
-18.10%97.28M
-24.68%47.21M
-20.25%118.77M
-34.70%62.68M
-33.42%148.94M
-17.24%95.99M
-47.43%223.68M
Cost of sales
17.88%-12.24M
7.36%-24.55M
0.39%-14.91M
7.31%-26.5M
8.47%-14.97M
27.55%-28.59M
45.16%-16.35M
41.74%-39.47M
27.98%-29.82M
75.88%-67.74M
Operating expenses
17.88%-12.24M
7.36%-24.55M
0.39%-14.91M
7.31%-26.5M
8.47%-14.97M
27.55%-28.59M
45.16%-16.35M
41.74%-39.47M
27.98%-29.82M
75.88%-67.74M
Gross profit
-20.42%23.49M
-22.64%54.75M
-8.46%29.52M
-21.51%70.78M
-30.40%32.25M
-17.62%90.18M
-29.99%46.33M
-29.80%109.47M
-11.27%66.18M
7.77%155.94M
Selling expenses
38.86%-2.08M
18.01%-7.99M
32.05%-3.4M
6.26%-9.75M
---5M
---10.4M
----
----
----
----
Administrative expenses
6.75%-22.88M
3.83%-51.17M
10.59%-24.53M
27.20%-53.21M
---27.44M
---73.09M
----
----
----
----
Profit from asset sales
----
----
----
----
----
---96.91M
---92.75M
----
----
--15.87M
Revaluation surplus
62.43%-52.96M
-21.00%-322.03M
-71.14%-140.98M
-117.21%-266.14M
-243.14%-82.38M
-28.10%-122.53M
-170.11%-24.01M
-272.39%-95.65M
-2.52%34.24M
-63.32%55.49M
-Changes in the fair value of investment property
62.43%-52.96M
-21.00%-322.03M
-71.14%-140.98M
-117.21%-266.14M
-243.14%-82.38M
-28.10%-122.53M
-170.11%-24.01M
-286.01%-95.65M
6.88%34.24M
-64.92%51.42M
-Changes in the fair value of derivative financial instruments
----
----
----
----
----
----
----
----
----
-13.42%4.06M
Impairment and provision
106.32%718K
122.36%14.41M
-4.45%-11.36M
-9.59%-64.46M
-109.78%-10.88M
-240.39%-58.82M
5.66%-5.18M
-193.68%-17.28M
-5,487.25%-5.5M
73.30%-5.88M
-Other impairment is provision
106.32%718K
122.36%14.41M
-4.45%-11.36M
-9.59%-64.46M
-109.78%-10.88M
-240.39%-58.82M
5.66%-5.18M
-193.68%-17.28M
-5,487.25%-5.5M
12.48%-5.88M
Special items of operating profit
25.30%-16.89M
-2.87%70.85M
-136.91%-22.61M
21.49%72.94M
-15.32%61.26M
41.15%60.03M
803,677.78%72.34M
342.53%42.53M
-99.97%9K
-225.52%-17.54M
Operating profit
59.28%-70.6M
3.47%-241.19M
-438.52%-173.36M
-18.11%-249.85M
-883.86%-32.19M
-641.41%-211.53M
-103.45%-3.27M
-80.84%39.07M
-33.05%94.93M
-29.19%203.87M
Financing cost
28.42%-58.33M
10.36%-155.52M
7.92%-81.48M
6.70%-173.5M
21.94%-88.49M
35.52%-185.95M
18.85%-113.36M
-15.36%-288.37M
-13.26%-139.7M
-5.81%-249.97M
Share of profits of associates
----
----
----
----
----
-83.03%1.16M
-88.02%1.16M
-29.35%6.84M
152.23%9.69M
935.72%9.68M
Special items of earning before tax
----
----
----
----
----
----
17.88%-45.78M
18.99%-89.35M
-7.88%-55.75M
16.35%-110.3M
Earning before tax
49.41%-128.93M
6.29%-396.71M
-111.17%-254.85M
-6.82%-423.35M
25.16%-120.68M
-19.44%-396.32M
-77.53%-161.26M
-126.17%-331.81M
-209.12%-90.83M
-85.10%-146.71M
Tax
-65.85%8.29M
33.73%51.11M
83.37%24.27M
111.79%38.22M
194.61%13.23M
28.78%18.05M
152.98%4.49M
190.60%14.01M
-1.47%-8.48M
61.11%-15.47M
After-tax profit from continuing operations
47.68%-120.64M
10.26%-345.59M
-114.59%-230.58M
-1.81%-385.13M
31.46%-107.45M
-19.03%-378.28M
-57.85%-156.76M
-95.96%-317.8M
-163.15%-99.31M
-36.24%-162.18M
After-tax profit from non-continuing business
----
----
----
----
----
50.47%-7.21M
---13.92M
---14.55M
----
----
Special items of earning after tax
----
----
----
----
----
50.47%-7.21M
---13.92M
---14.55M
----
----
Earning after tax
47.68%-120.64M
10.26%-345.59M
-114.59%-230.58M
0.09%-385.13M
37.05%-107.45M
-15.99%-385.48M
-71.87%-170.68M
-104.93%-332.35M
-163.15%-99.31M
-23.93%-162.18M
Minority shareholders should account for profits from continuing business
----
----
----
----
----
-295.62%-1.65M
---8.75M
--845K
----
----
Minority shareholders should account for non-continuing business profits
----
----
----
----
----
-696.78%-5.19M
---2K
--869K
----
----
Minority profit
72.00%-457K
94.40%-187K
4.39%-1.63M
51.13%-3.34M
80.49%-1.71M
-499.01%-6.84M
-298.26%-8.75M
-89.72%1.71M
-39.19%4.41M
2,168.73%16.67M
Shareholders should account for profits from continuing business
----
----
----
----
----
-18.19%-376.62M
---148.02M
---318.65M
----
----
Shareholders should account for profits from non-continuing business
----
----
----
----
----
86.90%-2.02M
---13.92M
---15.42M
----
----
Profit attributable to shareholders
47.51%-120.19M
9.53%-345.41M
-116.51%-228.95M
-0.83%-381.78M
34.70%-105.74M
-13.34%-378.64M
-56.12%-161.93M
-86.78%-334.06M
-130.51%-103.72M
-37.52%-178.85M
Basic earnings per share
47.50%-0.1028
9.53%-0.2954
-116.59%-0.1958
-0.83%-0.3265
34.73%-0.0904
-13.34%-0.3238
-56.14%-0.1385
50.62%-0.2857
42.37%-0.0887
-30.05%-0.5786
Diluted earnings per share
47.50%-0.1028
9.53%-0.2954
-116.59%-0.1958
-0.83%-0.3265
34.73%-0.0904
-13.34%-0.3238
-56.14%-0.1385
50.62%-0.2857
42.37%-0.0887
-30.05%-0.5786
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Auditor
--
National Health Accounting Firm Limited
--
National Health Accounting Firm Limited
--
National Health Accounting Firm Limited
--
National Health Accounting Firm Limited
--
National Health Accounting Firm Limited
(Q6)Sep 30, 2025(FY)Mar 31, 2025(Q6)Sep 30, 2024(FY)Mar 31, 2024(Q6)Sep 30, 2023(FY)Mar 31, 2023(Q6)Sep 30, 2022(FY)Mar 31, 2022(Q6)Sep 30, 2021(FY)Mar 31, 2021
Turnover -19.57%35.73M-18.48%79.3M-5.90%44.43M-18.10%97.28M-24.68%47.21M-20.25%118.77M-34.70%62.68M-33.42%148.94M-17.24%95.99M-47.43%223.68M
Operating income -19.57%35.73M-18.48%79.3M-5.90%44.43M-18.10%97.28M-24.68%47.21M-20.25%118.77M-34.70%62.68M-33.42%148.94M-17.24%95.99M-47.43%223.68M
Cost of sales 17.88%-12.24M7.36%-24.55M0.39%-14.91M7.31%-26.5M8.47%-14.97M27.55%-28.59M45.16%-16.35M41.74%-39.47M27.98%-29.82M75.88%-67.74M
Operating expenses 17.88%-12.24M7.36%-24.55M0.39%-14.91M7.31%-26.5M8.47%-14.97M27.55%-28.59M45.16%-16.35M41.74%-39.47M27.98%-29.82M75.88%-67.74M
Gross profit -20.42%23.49M-22.64%54.75M-8.46%29.52M-21.51%70.78M-30.40%32.25M-17.62%90.18M-29.99%46.33M-29.80%109.47M-11.27%66.18M7.77%155.94M
Selling expenses 38.86%-2.08M18.01%-7.99M32.05%-3.4M6.26%-9.75M---5M---10.4M----------------
Administrative expenses 6.75%-22.88M3.83%-51.17M10.59%-24.53M27.20%-53.21M---27.44M---73.09M----------------
Profit from asset sales -----------------------96.91M---92.75M----------15.87M
Revaluation surplus 62.43%-52.96M-21.00%-322.03M-71.14%-140.98M-117.21%-266.14M-243.14%-82.38M-28.10%-122.53M-170.11%-24.01M-272.39%-95.65M-2.52%34.24M-63.32%55.49M
-Changes in the fair value of investment property 62.43%-52.96M-21.00%-322.03M-71.14%-140.98M-117.21%-266.14M-243.14%-82.38M-28.10%-122.53M-170.11%-24.01M-286.01%-95.65M6.88%34.24M-64.92%51.42M
-Changes in the fair value of derivative financial instruments -------------------------------------13.42%4.06M
Impairment and provision 106.32%718K122.36%14.41M-4.45%-11.36M-9.59%-64.46M-109.78%-10.88M-240.39%-58.82M5.66%-5.18M-193.68%-17.28M-5,487.25%-5.5M73.30%-5.88M
-Other impairment is provision 106.32%718K122.36%14.41M-4.45%-11.36M-9.59%-64.46M-109.78%-10.88M-240.39%-58.82M5.66%-5.18M-193.68%-17.28M-5,487.25%-5.5M12.48%-5.88M
Special items of operating profit 25.30%-16.89M-2.87%70.85M-136.91%-22.61M21.49%72.94M-15.32%61.26M41.15%60.03M803,677.78%72.34M342.53%42.53M-99.97%9K-225.52%-17.54M
Operating profit 59.28%-70.6M3.47%-241.19M-438.52%-173.36M-18.11%-249.85M-883.86%-32.19M-641.41%-211.53M-103.45%-3.27M-80.84%39.07M-33.05%94.93M-29.19%203.87M
Financing cost 28.42%-58.33M10.36%-155.52M7.92%-81.48M6.70%-173.5M21.94%-88.49M35.52%-185.95M18.85%-113.36M-15.36%-288.37M-13.26%-139.7M-5.81%-249.97M
Share of profits of associates ---------------------83.03%1.16M-88.02%1.16M-29.35%6.84M152.23%9.69M935.72%9.68M
Special items of earning before tax ------------------------17.88%-45.78M18.99%-89.35M-7.88%-55.75M16.35%-110.3M
Earning before tax 49.41%-128.93M6.29%-396.71M-111.17%-254.85M-6.82%-423.35M25.16%-120.68M-19.44%-396.32M-77.53%-161.26M-126.17%-331.81M-209.12%-90.83M-85.10%-146.71M
Tax -65.85%8.29M33.73%51.11M83.37%24.27M111.79%38.22M194.61%13.23M28.78%18.05M152.98%4.49M190.60%14.01M-1.47%-8.48M61.11%-15.47M
After-tax profit from continuing operations 47.68%-120.64M10.26%-345.59M-114.59%-230.58M-1.81%-385.13M31.46%-107.45M-19.03%-378.28M-57.85%-156.76M-95.96%-317.8M-163.15%-99.31M-36.24%-162.18M
After-tax profit from non-continuing business --------------------50.47%-7.21M---13.92M---14.55M--------
Special items of earning after tax --------------------50.47%-7.21M---13.92M---14.55M--------
Earning after tax 47.68%-120.64M10.26%-345.59M-114.59%-230.58M0.09%-385.13M37.05%-107.45M-15.99%-385.48M-71.87%-170.68M-104.93%-332.35M-163.15%-99.31M-23.93%-162.18M
Minority shareholders should account for profits from continuing business ---------------------295.62%-1.65M---8.75M--845K--------
Minority shareholders should account for non-continuing business profits ---------------------696.78%-5.19M---2K--869K--------
Minority profit 72.00%-457K94.40%-187K4.39%-1.63M51.13%-3.34M80.49%-1.71M-499.01%-6.84M-298.26%-8.75M-89.72%1.71M-39.19%4.41M2,168.73%16.67M
Shareholders should account for profits from continuing business ---------------------18.19%-376.62M---148.02M---318.65M--------
Shareholders should account for profits from non-continuing business --------------------86.90%-2.02M---13.92M---15.42M--------
Profit attributable to shareholders 47.51%-120.19M9.53%-345.41M-116.51%-228.95M-0.83%-381.78M34.70%-105.74M-13.34%-378.64M-56.12%-161.93M-86.78%-334.06M-130.51%-103.72M-37.52%-178.85M
Basic earnings per share 47.50%-0.10289.53%-0.2954-116.59%-0.1958-0.83%-0.326534.73%-0.0904-13.34%-0.3238-56.14%-0.138550.62%-0.285742.37%-0.0887-30.05%-0.5786
Diluted earnings per share 47.50%-0.10289.53%-0.2954-116.59%-0.1958-0.83%-0.326534.73%-0.0904-13.34%-0.3238-56.14%-0.138550.62%-0.285742.37%-0.0887-30.05%-0.5786
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Auditor --National Health Accounting Firm Limited--National Health Accounting Firm Limited--National Health Accounting Firm Limited--National Health Accounting Firm Limited--National Health Accounting Firm Limited

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.04%
Sample Name
Sample Code
 -4.60%
Sample Name
Sample Code
 -6.30%
4
CNOOC
00883
-6.32%
5
YANCHANG PETRO
00346
-8.99%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -